AstraZeneca sues US over Medicare drug price negotiation plans

AstraZeneca has filed a lawsuit against the US government to prevent the Medicare health insurance plan from negotiating lower drug prices. The British drugmaker argues that the program would hinder the development of new medicines. AstraZeneca's legal challenge aims to protect access to medicines for rare conditions.